Periodic visual examinations during IntronA therapy are recommended particularly in patients with disorders that may be associated with retinopathy, such as diabetes mellitus or hypertension.
On suositeltavaa ajoittain tutkia erityisesti niiden IntronA- hoitoa saavien potilaiden silmät, joilla on retinopatiaan liittyviä sairauksia, kuten sokeritauti tai korkea verenpaine.